Clinical Trial Update: Study to Learn About Relapse Prevention of Hypericumextract (a Drug Based on the Plant St. John Wort) in Outpatients Suffering From Moderate Depressive Episodes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Hypericum extract (St. John’s Wort) for relapse prevention in outpatients with moderate depressive episodes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Hypericum extract (Hypericum extract)

Snippet

Sponsor: Bayer | Conditions: Moderate Depressive Episodes (Major Depression) | Phase 3 | Status: COMPLETED